Biotech Values

[drbio45]

There are probably 5 or six institutions that control sixty percent of the stock.

There is an expression, in for a dime in for a dollar. My feeling is that even if those funds had to put together ten million dollars to extend the runway, that would last a long time given the company's reduced burn.

Most of the biotechs that have gone bankrupt had debt of fifty to sixty million so it didn't make sense in those instances.

This company has two blockbuster ready for phase three drugs and one multihundred million, ready for phase three drugs I think the large holders would want to perserve their interests.